{"id":781761,"date":"2023-09-05T06:19:52","date_gmt":"2023-09-05T10:19:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/"},"modified":"2023-09-05T06:19:52","modified_gmt":"2023-09-05T10:19:52","slug":"prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/","title":{"rendered":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference"},"content":{"rendered":"
\n

WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK)<\/strong> (\u201cProKidney\u201d or the \u201cCompany\u201d), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference<\/strong>, being held in New York, NY from September 11 \u2013 14, 2023.<\/p>\n

Dr. Bertram\u2019s session is scheduled for Monday, September 11 at 12:15 pm ET. A live webcast will be available on the Events and Presentations section of ProKidney\u2019s investor relations website at https:\/\/investors.prokidney.com\/news-events\/events-and-presentations<\/a>.<\/p>\n

Investors attending the conference and interested in meeting with ProKidney\u2019s management team may request a meeting by contacting their Morgan Stanley representative.<\/p>\n

\n About ProKidney<\/strong>
\n
ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2018 after a decade of research. ProKidney\u2019s lead product candidate, REACT\u00ae (Renal Autologous Cell Therapy), is a first-of-its-kind, patented, proprietary autologous cellular therapy with the potential to preserve kidney function in patients at high risk of kidney failure. Late-stage CKD patients, Stage 3b – 4, are a key target population for REACT therapy. REACT has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program that launched in January 2022. For more information, visit www.prokidney.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>
\n
This press release includes \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. ProKidney\u2019s actual results may differ from its expectations, estimates and projections, and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as \u201cexpect,\u201d \u201cestimate,\u201d \u201cproject,\u201d \u201cbudget,\u201d \u201cforecast,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cbelieves,\u201d \u201cpredicts,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company\u2019s expectations with respect to financial results and expected cash runway, future performance, development and commercialization of products, if approved, the potential benefits and impact of the Company\u2019s products, if approved, potential regulatory approvals, the size and potential growth of current or future markets for the Company\u2019s products, if approved, the advancement of the Company\u2019s development programs into and through the clinic and the expected timing for reporting data, the making of regulatory filings or achieving other milestones related to the Company\u2019s product candidates, the advancement and funding of the Company\u2019s developmental programs generally, the realization of incentives under the purchase agreement, and expectations with respect to the Company\u2019s future manufacturing capabilities. Most of these factors are outside of the Company\u2019s control and are difficult to predict. Factors that may cause actual results to differ from the Company\u2019s expectations include, but are not limited to: market conditions; the inability to maintain the listing of the Company\u2019s Class A ordinary shares on the Nasdaq; the inability to implement business plans, forecasts, and other expectations or identify and realize additional opportunities, which may be affected by, among other things, competition and the ability of the Company to grow and manage growth profitably and retain its key employees; the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry; the inability of the Company to raise financing in the future; the inability of the Company to obtain and maintain regulatory clearances or approvals for its products, and any related restrictions and limitations of any cleared or approved products; the inability of the Company to identify, in-license or acquire additional technology; the inability of Company to compete with other companies currently marketing or engaged in the biologics market and in the area of treatment of kidney diseases; the size and growth potential of the markets for the Company\u2019s products, if approved, and its ability to serve those markets, either alone or in partnership with others; the Company\u2019s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company\u2019s financial performance; the Company\u2019s intellectual property rights; uncertainties inherent in cell therapy research and development, including the actual time it takes to initiate and complete clinical studies and the timing and content of decisions made by regulatory authorities; the fact that interim results from our clinical programs may not be indicative of future results; the impact of COVID-19 or geo-political conflict such as the war in Ukraine on the Company\u2019s business; and other risks and uncertainties included under the heading \u201cRisk Factors\u201d in the Company\u2019s most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company cautions readers that the foregoing list of factors is not exclusive and cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.<\/p>\n

\n Contacts:<\/strong>\n <\/p>\n

\n Corporate:<\/strong>
\n
Glenn Schulman, PharmD, MPH
SVP, Investor Relations
glenn.schulman@prokidney.com<\/a><\/p>\n

\n Investors:<\/strong>
\n
Burns McClellan
Lee Roth \/ Julia Weilman
lroth@burnsmc.com<\/a> \/ jweilman@burnsmc.com<\/a><\/p>\n

\n Media:<\/strong>
\n
Burns McClellan
Selina Husain \/ Robert Flamm, Ph.D.
shusain@burnsmc.com<\/a> \/ rflamm@burnsmc.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (\u201cProKidney\u201d or the \u201cCompany\u201d), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, being held in New York, NY from September 11 \u2013 14, 2023. Dr. Bertram\u2019s session is scheduled for Monday, September 11 at 12:15 pm ET. A live webcast will be available on the Events and Presentations section of ProKidney\u2019s investor relations website at https:\/\/investors.prokidney.com\/news-events\/events-and-presentations. Investors attending the conference and interested in meeting with ProKidney\u2019s management team may request a meeting by contacting … <\/p>\n

Continue reading “ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781761","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (\u201cProKidney\u201d or the \u201cCompany\u201d), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, being held in New York, NY from September 11 \u2013 14, 2023. Dr. Bertram\u2019s session is scheduled for Monday, September 11 at 12:15 pm ET. A live webcast will be available on the Events and Presentations section of ProKidney\u2019s investor relations website at https:\/\/investors.prokidney.com\/news-events\/events-and-presentations. Investors attending the conference and interested in meeting with ProKidney\u2019s management team may request a meeting by contacting … Continue reading "ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T10:19:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference\",\"datePublished\":\"2023-09-05T10:19:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/\"},\"wordCount\":916,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/\",\"name\":\"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=\",\"datePublished\":\"2023-09-05T10:19:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk","og_description":"WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (\u201cProKidney\u201d or the \u201cCompany\u201d), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, being held in New York, NY from September 11 \u2013 14, 2023. Dr. Bertram\u2019s session is scheduled for Monday, September 11 at 12:15 pm ET. A live webcast will be available on the Events and Presentations section of ProKidney\u2019s investor relations website at https:\/\/investors.prokidney.com\/news-events\/events-and-presentations. Investors attending the conference and interested in meeting with ProKidney\u2019s management team may request a meeting by contacting … Continue reading \"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-05T10:19:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference","datePublished":"2023-09-05T10:19:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/"},"wordCount":916,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/","name":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=","datePublished":"2023-09-05T10:19:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjEzMSM1Nzk1MDA2IzIyNDQyNzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prokidney-to-participate-in-fireside-chat-at-the-morgan-stanley-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781761"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781761\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}